Erratum: Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis (Journal of Neurology DOI 10.1007/s00415-009-5337-6);Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis

Journal of Neurology

Volumn 257, Issue 3, 2010, Pages 410-418

  Steffensen, Linn Hofsøy ^a,b   Mellgren, Svein Ivar ^a,b   Kampman, Margitta T ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

10 Foot timed tandem walk; Bone mineral density; Multiple sclerosis; Strength of grip; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL;

ADULT; AMBULATORY CARE; ARTICLE; BODY MASS; BONE DISEASE; BONE MASS; CALCIUM INTAKE; CONTROLLED STUDY; DEMOGRAPHY; DRUG BLOOD LEVEL; FOREARM; FUNCTIONAL ASSESSMENT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM; SEX DIFFERENCE; SPINE; VITAMIN INTAKE; WALKING;

EID: 77951208250     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5470-2     Document Type: Erratum

References (41)

1. A Altintas G Saruhan-Direskeneli G Benbir M Demir S Purisa 2008 The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis? J Neurol Sci 276 41 44 10.1016/j.jns.2008.08.031 18845306
2. G Aydin E Atalar I Keles A Tosun G Zog H Keles S Orkun 2006 Predictive value of grip strength for bone mineral density in males: site specific or systemic? Rheumatol Int 27 125 129 10.1007/s00296-006-0178-4 16932964 (Pubitemid 46088268)
3. KE Bainbridge M Sowers X Lin SD Harlow 2004 Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women Osteoporos Int 15 439 446 10.1007/s00198-003-1562-5 15205714 (Pubitemid 38843171)
4. HA Bischoff-Ferrari T Dietrich EJ Orav B Dawson-Hughes 2004 Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults Am J Med 116 634 639 10.1016/j.amjmed.2003.12.029 1:CAS:528:DC%2BD2cXjt1SisrY%3D 15093761 (Pubitemid 38490539)
5. Bonnick SL (2004) Bone densitometry in clinical practice. Application and interpretation. Humana Press Inc, Totowa
6. F Cosman J Nieves L Komar G Ferrer J Herbert C Formica V Shen R Lindsay 1998 Fracture history and bone loss in patients with MS Neurology 51 1161 1165 1:STN:280:DyaK1cvlt1yjug%3D%3D 9781548 (Pubitemid 28473419)
7. N Emaus GK Berntsen RM Joakimsen V Fonnebo 2005 Longitudinal changes in forearm bone mineral density in women and men aged 25-44 years: the Tromso study: a population-based study Am J Epidemiol 162 633 643 10.1093/aje/kwi258 1:STN:280:DC%2BD2MvpvFGhsw%3D%3D 16120708 (Pubitemid 41437362)
8. CA Formica F Cosman J Nieves J Herbert R Lindsay 1997 Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use Calcif Tissue Int 61 129 133 10.1007/s002239900309 1:CAS:528:DyaK2sXltFWit7o%3D 9236259 (Pubitemid 27315226)
9. Helsedirektoratet (2008) [Recommended intake of vitamin D and calcium]. Available at: http://www.shdir.no. Accessed 6 July 2009
10. J Herbert K Jakubowska-Sadowska HK Russell LE Kasten N Layer A Glueck M Frankel JT Fromm M DelBene 2006 The timed tandem walk is a more informative measure of mild impairment in patients with multiple sclerosis than the 25-foot walk Mult Scler 12 S87 Abstract
11. A Hjartaker LF Andersen E Lund 2007 Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-h dietary recalls. The Norwegian Women and Cancer Study Public Health Nutr 10 1094 1103 10.1017/S1368980007702872 17381903 (Pubitemid 47367592)
12. MF Holick 2007 Vitamin D deficiency N Engl J Med 357 266 281 10.1056/NEJMra070553 1:CAS:528:DC%2BD2sXotVejsbc%3D 17634462 (Pubitemid 47080391)
13. C Hotermans D Dive M Rinkin M Leroy M Malaise G Moonen N Franchimont 2006 Hip bone mineral density is correlated with EDSS in patients with multiple sclerosis J Neurol 253 ii126 Abstract
14. MT Kampman M Brustad 2008 Vitamin D: a candidate for the environmental effect in multiple sclerosis-observations from Norway Neuroepidemiology 30 140 146 10.1159/000122330 18382112 (Pubitemid 351667793)
15. MT Kampman LH Steffensen 2009 Comment on Shuhaibar et al.: favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis Ir J Med Sci 178 235 236 10.1007/s11845-009-0275-y 1:STN:280: DC%2BD1MvgtFCmuw%3D%3D 19184608
16. MT Kampman T Wilsgaard SI Mellgren 2007 Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle J Neurol 254 471 477 10.1007/s00415-006-0395-5 1:STN:280:DC%2BD2s3psFSksA%3D%3D 17377831 (Pubitemid 46786722)
17. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237
18. EM Lewiecki 2005 Premenopausal bone health assessment Curr Rheumatol Rep 7 46 52 10.1007/s11926-005-0008-9 15760580
19. WI McDonald A Compston G Edan D Goodkin HP Hartung FD Lublin HF McFarland DW Paty CH Polman SC Reingold M Sandberg-Wollheim W Sibley A Thompson NS van den BY Weinshenker JS Wolinsky 2001 Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 50 121 127 10.1002/ana.1032 1:STN:280: DC%2BD38%2FitFOhug%3D%3D 11456302 (Pubitemid 32591472)
20. KB Michels WC Willett BI Graubard RL Vaidya MM Cantwell LB Sansbury MR Forman 2007 A longitudinal study of infant feeding and obesity throughout life course Int J Obes (Lond) 31 1078 1085 10.1038/sj.ijo.0803622 1:STN:280:DC%2BD2svgtlKmtg%3D%3D (Pubitemid 46987776)
21. MC Mojtahedi EM Snook RW Motl EM Evans 2008 Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition J Rehabil Res Dev 45 851 861 10.1682/JRRD.2007.10. 0159 19009471
22. MSFC administration and scoring manual. Available at: http://www.nationalmssociety.org. Accessed 6 July 2009
23. KL Munger LI Levin BW Hollis NS Howard A Ascherio 2006 Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2832 2838 10.1001/jama.296.23.2832 1:CAS:528:DC%2BD28XhtlCqtL3J 17179460 (Pubitemid 44969183)
24. J Nieves F Cosman J Herbert V Shen R Lindsay 1994 High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis Neurology 44 1687 1692 1:STN:280:DyaK2M%2Fit1alsw%3D%3D 7936297 (Pubitemid 24286648)
25. JH Noseworthy C Lucchinetti M Rodriguez BG Weinshenker 2000 Multiple sclerosis N Engl J Med 343 938 952 10.1056/NEJM200009283431307 1:STN:280:DC%2BD3cvlvF2quw%3D%3D 11006371
26. S Ozgocmen S Bulut N Ilhan A Gulkesen O Ardicoglu Y Ozkan 2005 Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity J Bone Miner Metab 23 309 313 10.1007/s00774-005-0604-9 15981027 (Pubitemid 40875090)
27. KE Poole JE Compston 2006 Osteoporosis and its management BMJ 333 1251 1256 10.1136/bmj.39050.597350.47 1:CAS:528:DC%2BD2sXht1Siur0%3D 17170416 (Pubitemid 46043106)
28. LG Raisz 2005 Clinical practice. Screening for osteoporosis N Engl J Med 353 164 171 10.1056/NEJMcp042092 1:CAS:528:DC%2BD2MXmtFCgtrY%3D 16014886 (Pubitemid 41058348)
29. SR Schwid AD Goodman JE Puzas MP McDermott DH Mattson 1996 Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis Arch Neurol 53 753 757 1:STN:280:DyaK28zis1WktQ%3D%3D 8759981
30. JJ Stepan E Havrdova M Tyblova D Horakova V Ticha I Novakova V Zikan 2004 Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids Clin Chim Acta 348 147 154 10.1016/j.cccn.2004.05.012 1:CAS:528:DC%2BD2cXnsFSksLY%3D 15369748 (Pubitemid 39209013)
31. H Takayanagi 2007 Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems Nat Rev Immunol 7 292 304 10.1038/nri2062 1:CAS:528:DC%2BD2sXjtlyhurc%3D 17380158 (Pubitemid 46480961)
32. A Tenenhouse L Joseph N Kreiger S Poliquin TM Murray L Blondeau C Berger DA Hanley JC Prior 2000 Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos) Osteoporos Int 11 897 904 10.1007/s001980070050 1:STN:280:DC%2BD3M7isV2msQ%3D%3D 11199195 (Pubitemid 32049481)
33. S Tuzun A Altintas I Karacan S Tangurek S Saip A Siva 2003 Bone status in multiple sclerosis: beyond corticosteroids Mult Scler 9 600 604 10.1191/1352458503ms966oa 14664473 (Pubitemid 37479409)
34. A Vainionpaa R Korpelainen J Leppaluoto T Jamsa 2005 Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women Osteoporos Int 16 191 197 10.1007/s00198-004-1659-5 15221206 (Pubitemid 40193207)
35. IAF van der Mei L Blizzard AL Ponsonby T Dwyer 2006 Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis Cancer Epidemiol Biomarkers Prev 15 1538 1544 10.1158/1055-9965.EPI-05-0969 16896046 (Pubitemid 44299329)
36. IAF van der Mei AL Ponsonby T Dwyer L Blizzard BV Taylor T Kilpatrick H Butzkueven AJ McMichael 2007 Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia J Neurol 254 581 590 10.1007/s00415-006-0315-8 17426912 (Pubitemid 46781963)
37. SF Vondracek LB Hansen MT McDermott 2009 Osteoporosis risk in premenopausal women Pharmacotherapy 29 305 317 10.1592/phco.29.3.305 19249949
38. B Weinstock-Guttman E Gallagher M Baier L Green J Feichter K Patrick C Miller K Wrest M Ramanathan 2004 Risk of bone loss in men with multiple sclerosis Mult Scler 10 170 175 10.1191/1352458504ms993oa 15124763 (Pubitemid 38499910)
39. B Weinstock-Guttman J Hong R Santos M Tamano-Blanco D Badgett K Patrick M Baier J Feichter E Gallagher N Garg M Ramanathan 2006 Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients Mult Scler 12 541 550 10.1177/1352458506070605 1:CAS:528:DC%2BD28Xht12qsL7P 17086898 (Pubitemid 46940626)
40. Writing group for the ISCD position developement conference 2004 Diagnosis of osteoporosis in men, premenopausal women, and children J Clin Densitom 7 17 26 10.1385/JCD:7:1:17 (Pubitemid 38223461)
41. M Zorzon R Zivadinov L Locatelli D Giuntini M Toncic A Bosco D Nasuelli A Bratina MA Tommasi RA Rudick G Cazzato 2005 Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis Eur J Neurol 12 550 556 10.1111/j.1468-1331.2005.00988.x 1:STN:280:DC%2BD2MzhtFWgtw%3D%3D 15958096 (Pubitemid 40956813)